Variation in Fluids Administered in Shock

Shock Clinical Trial

— VOLUME  

Official title:

Observation of Variation in Fluids Administered and Characterization of Vasopressor Requirements in Shock

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03190408
• Other study ID #: 2017-7860
• Status: Completed
• Start date: September 1, 2017
• Est. completion date: February 1, 2018

Study information

• Verified date: July 2020
• Source: Montefiore Medical Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

To conduct a multicenter observational cohort study to determine the variability in fluid resuscitation in shock in a broad range of areas in hospitals and treatment areas.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1639
• Est. completion date: February 1, 2018
• Est. primary completion date: February 1, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Age = 18 years admitted to the participating hospital.

• Patients in the emergency department, intensive care unit, PACU, or any hospital floor. For patients not in the ICU, there must be plans to transfer to an intensive care unit when an ICU bed is available for patient.

• Patients with shock as defined by:

• Need for vasopressor (dopamine, norepinephrine, or epinephrine at any dose) to keep MAP > 65 mmHg Or

• Systolic BP < 90 mmHg

Exclusion Criteria:

• Patients previously enrolled into this study.

• Patients who were in the operating room at time of shock and fluid bolus.

• Patients admitted to an ICU after cardiac surgery Patients with primarily cardiogenic shock as etiology for their shock

• Patients transferred from another hospital or emergency room to the study hospital.

Related Conditions & MeSH terms

• Shock

Intervention

Other:
• Fluids
Fluids Administered in Shock

Locations

Country	Name	City	State
United States	Montefiore Medical Center	Bronx	New York

Sponsors (1)

Lead Sponsor	Collaborator
Montefiore Medical Center

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Method used to guide volume resuscitation	Characterize the method used to guide volume resuscitation and vasopressor use in patients with shock	7 days